The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma.
Saved in:
| Title: | The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma. |
|---|---|
| Authors: | Hsu YC; Liver Disease Prevention and Treatment Research Foundation, Taiwan; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei City, Taiwan., Wu MC; Liver Disease Prevention and Treatment Research Foundation, Taiwan., Chen CH; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei City, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei City, Taiwan., Lee YT; Liver Disease Prevention and Treatment Research Foundation, Taiwan., Lin CI; Liver Disease Prevention and Treatment Research Foundation, Taiwan., Chou HC; Liver Disease Prevention and Treatment Research Foundation, Taiwan., Lee HS; Liver Disease Prevention and Treatment Research Foundation, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei City, Taiwan., Wang LF; Liver Disease Prevention and Treatment Research Foundation, Taiwan., Sheu JC; Liver Disease Prevention and Treatment Research Foundation, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei City, Taiwan., Weng MT; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University, Taipei City, Taiwan; Department of Medical Research, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan. Electronic address: G05157@hch.gov.tw. |
| Source: | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2026 Mar; Vol. 196, pp. 119102. Date of Electronic Publication: 2026 Feb 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
